News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
882,363 Results
Type
Article (88693)
Company Profile (816)
Press Release (792826)
Multimedia
Podcasts (234)
Webinars (35)
Section
Business (233553)
Career Advice (4161)
Deals (39966)
Drug Delivery (175)
Drug Development (91663)
Employer Resources (207)
FDA (18543)
Job Trends (17480)
News (398642)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3049)
Academic (2)
Accelerated approval (54)
Adcomms (40)
Allergies (189)
Alliances (56988)
ALS (228)
Alzheimer's disease (1956)
Antibody-drug conjugate (ADC) (528)
Approvals (18860)
Artificial intelligence (841)
Autoimmune disease (342)
Automation (62)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (209)
Brain cancer (84)
Breast cancer (818)
Cancer (6362)
Cardiovascular disease (545)
Career advice (3595)
Career pathing (51)
CAR-T (369)
CDC (76)
Celiac Disease (3)
Cell therapy (1041)
Cervical cancer (51)
Clinical research (78696)
Collaboration (2306)
Company closure (8)
Compensation (1462)
Complete response letters (103)
COVID-19 (3036)
CRISPR (121)
C-suite (1245)
Cystic fibrosis (166)
Data (8364)
Decentralized trials (3)
Denatured (89)
Depression (190)
Dermatology (94)
Diabetes (647)
Diagnostics (7551)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (414)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (311)
Earnings (102459)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138146)
Executive appointments (1176)
FDA (22513)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1889)
Gene editing (267)
Generative AI (87)
Gene therapy (841)
GLP-1 (1259)
Government (5553)
Grass and pollen (8)
Guidances (416)
Healthcare (21199)
HIV (91)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (106)
Immunology and inflammation (351)
Immuno-oncology (109)
Indications (197)
Infectious disease (3424)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (309)
Interviews (820)
IPO (17996)
IRA (61)
Job creations (5206)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (117)
Layoffs (683)
Leadership (52)
Legal (10171)
Liver cancer (109)
Longevity (36)
Lung cancer (835)
Lymphoma (447)
Machine learning (65)
Management (66)
Manufacturing (1183)
MASH (219)
Medical device (15254)
Medtech (15392)
Mergers & acquisitions (23249)
Metabolic disorders (1736)
mRNA (258)
Multiple sclerosis (202)
NASH (24)
Neurodegenerative disease (488)
Neuropsychiatric disorders (125)
Neuroscience (3649)
Neurotech (2)
NextGen: Class of 2026 (7714)
Non-profit (5140)
Now hiring (80)
Obesity (835)
Opinion (371)
Ovarian cancer (238)
Pain (281)
Pancreatic cancer (327)
Parkinson's disease (404)
Partnered (39)
Patents (639)
Patient recruitment (727)
Peanut (67)
People (67870)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24322)
Phase 2 (34185)
Phase 3 (25696)
Pipeline (9314)
Policy (394)
Postmarket research (3559)
Preclinical (10949)
Press Release (72)
Prostate cancer (332)
Psychedelics (68)
Radiopharmaceuticals (362)
Rare diseases (1224)
Real estate (7461)
Recruiting (81)
Regulatory (30236)
Reports (77)
Research institute (2766)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (194)
Series A (318)
Series B (229)
Service/supplier (28)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4368)
State (2)
Stomach cancer (21)
Supply chain (143)
Tariffs (104)
The Weekly (142)
Vaccines (1289)
Venture capital (128)
Weight loss (574)
Women's health (136)
Worklife (24)
Date
Today (156)
Last 7 days (688)
Last 30 days (3695)
Last 365 days (33085)
2026 (14719)
2025 (33225)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (394)
Arkansas (16)
Asia (52178)
Australia (9179)
California (14094)
Canada (3948)
China (1498)
Colorado (604)
Connecticut (622)
Delaware (432)
Europe (120338)
Florida (2088)
Georgia (461)
Hawaii (4)
Idaho (69)
Illinois (1202)
India (100)
Indiana (652)
Iowa (25)
Japan (572)
Kansas (142)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1711)
Massachusetts (10280)
Michigan (421)
Minnesota (786)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3732)
New Mexico (34)
New York (3693)
North Carolina (1905)
North Dakota (11)
Northern California (6988)
Ohio (437)
Oklahoma (26)
Oregon (55)
Pennsylvania (2792)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5517)
Tennessee (223)
Texas (2285)
United States (50391)
Utah (422)
Vermont (1)
Virginia (357)
Washington D.C. (88)
Washington State (1159)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 882,363 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MustGrow Announces First Quarter 2026 Financial Results
May 28, 2026
·
5 min read
Press Releases
Baptist Health South Florida and The START Center for Cancer Research Announce Strategic Partnership to Expand Patient Access to Early-Phase Cancer Trials
New START site to be established in collaboration with Baptist Health Herbert Wertheim Cancer Institute will bring novel oncology therapies closer to patients across South Florida
May 28, 2026
·
1 min read
Press Releases
Augurex Named ADLM 2026 Disruptive Technology Award Finalist
• Augurex’s SPINEstat® (Anti-14-3-3eta Multiplex for axial spondyloarthritis) test has been selected as a finalist in the ADLM 2026 Disruptive Technology Award, one of laboratory medicine’s most competitive recognition programs. • Augurex will present at ADLM 2026 on July 27 in Anaheim, CA, with a dedicated finalist kiosk on the Expo Floor July 28–30. • The recognition underscores Augurex’s leadership in developing biomarker-driven diagnostics that address critical unmet needs across autoimmune and inflammatory diseases.
May 28, 2026
·
1 min read
Press Releases
Sino Biological’s Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab’s Protein Design Study Published in Nature Communications
May 28, 2026
·
3 min read
Press Releases
Beren Therapeutics Announces FDA Extension of Review Period for New Drug Application (NDA) for Adrabetadex for the Treatment of Infantile-Onset Niemann-Pick Disease, Type C
May 28, 2026
·
3 min read
Press Releases
EnPlusOne Biosciences Welcomes Biotech Veteran, Jim Weissman, to Board of Directors
May 28, 2026
·
3 min read
Press Releases
Acupath Laboratories Integrates AI-Powered Prostate Cancer Risk Stratification Tool into its Digital Pathology Diagnostic Pathway
May 28, 2026
·
3 min read
Press Releases
Avenzo Therapeutics Announces First Patient Dosed in Combination Cohort Evaluating CDK4 Selective Inhibitor (AVZO-023) with CDK2 Selective Inhibitor (AVZO-021) In Ongoing Phase 1/2 ORION-1 Study
May 28, 2026
·
2 min read
Press Releases
Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO
May 28, 2026
·
6 min read
Press Releases
Rubedo’s RLS-1496 Reduces Actinic Keratosis Pre-Cancerous Skin Lesions by 46% at Four Weeks with Minimal Irritation in Preliminary Results of Phase 1b/2a Study
May 28, 2026
·
9 min read
1 of 88,237
Next
